Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Not Applicable

Completed

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT03092882
• Lead Sponsor: Evidation Health

Brief Summary

The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-03
• Study First Submitted: 2017-03-22
• Study First Submitted QC: 2017-03-27
• Study First Posted: 2017-03-28
• Primary Completion: 2018-02-07
• Study Completion: 2018-02-07
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-23
• Last Update Posted: 2019-06-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 607

Inclusion Criteria

• Humana Medicare Advantage member
• Type 2 diabetes diagnosis
• HbA1c levels ≥ 8.0% verified by lab test

Exclusion Criteria

• Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease
• Not fluent in English
• Humana membership is part of a Full or Global risk arrangement
• Enrolled in Humana at Home Care Management

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change from Baseline in A1c at 6 months	Baseline and 6 months	Change in A1c from study baseline to study end

Trial Locations

Locations (1)

Evidation Health; 🇺🇸 San Mateo, California, United States